Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

MLA

Chung Pin Li, et al. “Association between Dipeptidyl Peptidase-4 Inhibitors and Risk of Bullous Pemphigoid in Patients with Type 2 Diabetes: A Population-Based Cohort Study.” Diabetes Research and Clinical Practice, vol. 171, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....11ef95df83fb4b9e81a644fca9ba999b&authtype=sso&custid=ns315887.

APA

Chung Pin Li, Chun Ying Wu, Yiing Jenq Chou, Yi Hsian Lin, Chen Yi Wu, & Yun Ting Chang. (2020). Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study. Diabetes Research and Clinical Practice, 171.

Chicago

Chung Pin Li, Chun Ying Wu, Yiing Jenq Chou, Yi Hsian Lin, Chen Yi Wu, and Yun Ting Chang. 2020. “Association between Dipeptidyl Peptidase-4 Inhibitors and Risk of Bullous Pemphigoid in Patients with Type 2 Diabetes: A Population-Based Cohort Study.” Diabetes Research and Clinical Practice 171 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....11ef95df83fb4b9e81a644fca9ba999b&authtype=sso&custid=ns315887.